Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians | Luke Timmerman | 01/13/14 | Boston |
Yub Lands $12,000,000 New Funding | VentureDeal | 11/19/13 | San Francisco |
Redfin Raises $50M From Tiger Global, T. Rowe Price, Others | Benjamin Romano | 11/14/13 | Seattle |
MongoDB Secures $150,000,000 New Financing Round | VentureDeal | 10/04/13 | New York |
Pure Storage Garners $150,000,000 Series E Round | VentureDeal | 08/29/13 | San Francisco |
Eventbrite Secures $60,000,000 New Round | VentureDeal | 04/22/13 | San Francisco |
New Relic Garners $80,000,000 New Funding | VentureDeal | 02/06/13 | San Francisco |
Ultragenyx, Led by BioMarin Vet, Snags $75M for Ultra-Rare Diseases | Luke Timmerman | 12/20/12 | San Francisco |
Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round | VentureDeal | 12/20/12 | San Francisco |
EverNote Garners $70,000,000 Series D Financing | VentureDeal | 05/03/12 | San Francisco |
Castlight Health Receives $100,000,000 Series D Funding Round | VentureDeal | 05/01/12 | San Francisco |
oDesk Secures $15,000,000 Series D Funding | VentureDeal | 03/22/12 | San Francisco |
Apptio Receives $50,000,000 Series D Financing | VentureDeal | 03/16/12 | Seattle |
Apptio Adds $50M to “War Chest,” Plans to Double Sales Bookings | Curt Woodward | 03/15/12 | Seattle |
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News | Erin Kutz | 06/24/11 | Boston |
Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News | Erin Kutz | 06/22/11 | Boston |
Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs | Luke Timmerman | 06/21/11 | Boston |
Gates Foundation Dishes Out Latest $100K Grants for ‘Out of the Box’ Global Health Ideas | Luke Timmerman | 04/28/11 | Seattle |
Investors Pour $200M into Twitter | Wade Roush | 12/16/10 | San Francisco |
PacBio Nabs $109M to Make Cheaper, Faster Gene Sequencing Tools | Luke Timmerman | 07/14/10 | San Francisco |
The Show Must Go On: Invest Northwest Forges Ahead Despite Grim Biotech Climate | Luke Timmerman | 02/17/09 | Seattle |
Buy-Side Experts See Major Changes Afoot for Biotech Amid Financial Crisis | Ryan McBride | 10/30/08 | National |